E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2018 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
DateTitle 
10/16/18Quest Diagnostics to Present New Insights from Genetic Testing at the 2018 American Society of Human Genetics Annual Meeting
Four Presentations Reveal Genetic Insights from Quest's Advanced Diagnostics SECAUCUS, N.J., Oct. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of four studies at the 2018 American Society of Human Genetics Meeting (ASHG), October 16 – 20, 2018 in San Diego (Quest Diagnostics booth 1514). These studies by Quest Diagnostics researchers eval... 
Printer Friendly Version
10/10/18Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World
The GDN brings together leading diagnostics services providers to share expertise and drive worldwide diagnostics innovation SECAUCUS, N.J., Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today jointly with other leading diagnostic services providers the formation and launch of the Global Diagnostics Network (GDN). The GDN is a strategic working group of diagnostic laboratories, each committed to unleashi... 
Printer Friendly Version
10/10/18Quest Diagnostics Completes Acquisition of Provant Health, Extending Health and Wellness Services
Bolsters company's expert screening and intervention services for employers and managed populations SECAUCUS, N.J., Oct. 10, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its subsidiary, Summit Health Inc. ("Summit"), has completed the previously disclosed acquisition of the assets of Hooper Holmes, Inc. d/b/a Provant Health (OTCMKTS: HPHWQ) ("Provant Health"), a provider of employer health and wellnes... 
Printer Friendly Version
10/09/18Quest Diagnostics Earns Gold Status in National Business Group on Health's Best Employers for Healthy Lifestyles Awards
SECAUCUS, N.J., Oct. 9, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it received the Gold Award in the 2018 Best Employers for Healthy Lifestyles awards from the National Business Group on Health (NBGH). The awards recognized 49 employers that have an exceptional commitment to improving the lives of their employees through their overall well-being, productivity and quality of life. The Gold Award is pres... 
Printer Friendly Version
10/05/18Quest Diagnostics To Release Third Quarter 2018 Financial Results On October 23
SECAUCUS, N.J., Oct. 5, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2018 results on Tuesday, October 23, 2018, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed by dialing 888-455-0391 within the U.S. and Ca... 
Printer Friendly Version
10/05/18Quest Diagnostics to Sell India Diagnostics Business to Strand Life Sciences
SECAUCUS, N.J. and BANGALORE, India, Oct. 5, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bangalore-based specialized diagnostics company. "This acquisition is an important addition to our network of 24 diagnostic labs across India, especially as we continue to expand our work in oncology... 
Printer Friendly Version
09/27/18Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics
PhenoPath deepens Quest's presence in the Pacific Northwest while extending the company's capabilities in anatomic pathology and molecular oncology SECAUCUS, N.J. and SEATTLE, Sept. 27, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. Based in Seattle, PhenoPath p... 
Printer Friendly Version
09/26/18Quest Diagnostics Partners With RMC Health System to Deliver High-Value, Innovative Laboratory Services
SECAUCUS, N.J. and ANNISTON, Ala., Sept. 26, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide supply chain expertise, as well as p... 
Printer Friendly Version
09/25/18Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Acquisition to broaden access to tuberculosis (TB) IGRA blood testing in the United States SECAUCUS, N.J. and OXFORD, England and MARLBOROUGH, Mass., Sept. 25, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced the signing of a definitive agreement under which Quest will acquire the U.S. laboratory services business of Oxf... 
Printer Friendly Version
09/24/18Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
Bolsters Quest's leadership in advanced diagnostics for women's and reproductive health SECAUCUS, N.J. and WOBURN, Mass., Sept. 24, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services. About 10 percent of women of child-bearing age in the United States have difficulty getting or staying pr... 
Printer Friendly Version
09/07/18Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Sept. 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City.  Stephen Rusckowski, Chairman, President and CEO and Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation i... 
Printer Friendly Version
09/06/18Quest Diagnostics Health Trends™ Study Finds Drug Misuse Rates Remain Constant at High Levels, and Dangerous Opioid-related Drug Combining Is Prevalent
- More than half of Americans tested misused their prescription drugs in 2017 - Among patients in general care, use of non-prescribed medications and illicit drugs declined, but is still prevalent - Among patients in treatment for substance use disorder (SUD), misuse of heroin and prescription fentanyl surged nearly 400 percent; among patients testing positive for heroin, the rate of mixing with fentanyl nearly doubled - Drug mixing is the most frequent form of misuse with one-in-five t... 
Printer Friendly Version
08/17/18Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Aug. 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on October 22, 2018 to shareholders of record of Quest Diagnostics common stock on October 5, 2018. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived fr... 
Printer Friendly Version
08/16/18Quest Diagnostics Earns Gold Status in American Heart Association's Workplace Health Achievement Index
SECAUCUS, N.J., Aug. 16, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it achieved gold status in the American Heart Association's 2018 Workplace Health Achievement Index, ranking the company's workplace health program among the best in the nation. The American Heart Association created the Index with its CEO Roundtable members, a leadership collaborative of more than ... 
Printer Friendly Version
07/30/18New Quest Diagnostics Data Shows Lyme Disease Prevalence Increasing and is Now Present in New U.S. States
- Number of positive tests for Lyme disease increased significantly between 2016 and 2017. - Historically concentrated in Pennsylvania and New England states, Lyme disease has been detected in each of the 50 United States and the District of Columbia. - Outside of the northeastern U.S., California and Florida - states not historically associated with significant rates of Lyme disease - saw the largest absolute increases in positive Lyme disease test results. - Notable increases also obs... 
Printer Friendly Version
07/24/18Quest Diagnostics Reports Second Quarter 2018 Financial Results
-- Second quarter revenues of $1.92 billion, up 3.0% from 2017 -- Second quarter reported diluted EPS of $1.57, up 14.4% from 2017 -- Second quarter adjusted diluted EPS excluding amortization of $1.75, up 20.5% from 2017 -- Narrows outlook for full year 2018 revenues and diluted EPS. Revenues now expected to be between $7.70 billion and $7.74 billion. Reported diluted EPS now expected to be between $5.50 and $5.64 and adjusted diluted EPS excluding amortization expense now expected to ... 
Printer Friendly Version
07/17/18New Study Reveals Stalled Progress Toward Value-Based Care
Third annual study from Quest Diagnostics of health plan executives and physicians suggests physicians need better tools, data access and less complex quality measures to spur adoption SECAUCUS, N.J., July 17, 2018 /PRNewswire/ --  2018 QUEST DIAGNOSTICS STUDY FINDS: Physicians and health plan executives agreed healthcare has made little progress toward value-based care since last year – more than two-thirds (67 percent) of physicians and he... 
Printer Friendly Version
07/11/18Quest Diagnostics To Release Second Quarter 2018 Financial Results On July 24
SECAUCUS, N.J., July 11, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2018 results on Tuesday, July 24, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 773-756-0467,... 
Printer Friendly Version
06/23/18One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study
Late-breaker presentation at the 78th American Diabetes Association Scientific Sessions shows glucose levels and hemoglobin A1c in one third of at risk participants fell to normal levels; more than one-quarter of participants lost five percent or more of body weight SECAUCUS, N.J. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Employer wellness programs that combine laboratory and biometric screening with digital behavioral counseling can significantly reduce employees' risk of developing c... 
Printer Friendly Version
06/11/18Quest Diagnostics Unveils Quanum™ Enterprise Content Solutions, Formerly Named ChartMaxx®
Name change coincides with refreshed 2018 product release featuring integrated deep search and other capabilities from Ephesoft to help healthcare organizations improve patient care, drive operational efficiencies and lower costs SECAUCUS, N.J., June 11, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled the newest version of its Quanum Enterprise Content Management Solution, featuring Smart Capture® from Ephesof... 
Printer Friendly Version
06/04/18Quest Diagnostics To Speak At The William Blair 38th Annual Growth Stock Conference
SECAUCUS, N.J., June 4, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the William Blair 38th Annual Growth Stock Conference in Chicago. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, June 13, 2018 at 3:40 p.m. ... 
Printer Friendly Version
05/24/18UnitedHealthcare Establishes Long-term Strategic Partnership with Quest Diagnostics
Beginning Jan. 1, 2019, Quest will be participating as a national provider of laboratory services for all UnitedHealthcare plan participants Partnership will include broad range of value-based programs, rewarding high quality, easily accessible laboratory services at the best value and real-time data sharing to drive more personalized care support MINNEAPOLIS and SECAUCUS, N.J., (May 24, 2018) – UnitedHealthcare and Quest Diagnostics (NYSE: DGX) have established a long-term strategic partnershi... 
Printer Friendly Version
05/23/18Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions, Finds Study from Quest Diagnostics
- Nearly all physicians (95%) surveyed say they entered primary care to care for the "whole patient," yet 66 percent say they don't have time to address social and behavioral issues that could affect health. - Fears related to medication nonadherence, falling at home, and being a burden on caregivers cited as concerns by physicians and patients -- but often not discussed during the physician visit. - Eighty-four percent of physicians say Chronic Care Management services could be an extensi... 
Printer Friendly Version
05/17/18Quest Diagnostics adds Helen Torley to Board of Directors
SECAUCUS, N.J., May 17, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Helen I. Torley was elected to serve as a director at the company's 2018 Annual Meeting of Stockholders, expanding the Board of Directors to 10 members. Dr. Torley has served since 2014 as President, Chief Executive Officer and director of Halozyme Therapeutics, Inc., a biotechnology company focused ... 
Printer Friendly Version
05/14/18Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., May 14, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share, payable on July 23, 2018 to shareholders of record of Quest Diagnostics common stock on July 9, 2018. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the ... 
Printer Friendly Version
05/08/18Workforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results
Prescription opiate positivity rate drops by double digits, while cocaine rises by double digits in certain states Methamphetamine positivity skyrockets in Midwestern and Southern United States Marijuana positivity rises considerably in states that recently enacted recreational use statutes, finds national analysis by Quest Diagnostics SECAUCUS, N.J., May 8, 2018 /PRNewswire/ -- Driven by increases in cocaine, methamphetamine and marijuana, drug use by the American workforce remains at ... 
Printer Friendly Version
05/07/18Forbes Names Quest Diagnostics One of America's Best Large Employers
SECAUCUS, N.J., May 7, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2018.  Quest was among one of only thirteen companies in the Health Care and Equipment Services Category, and the only diagnostic information services company to attain the designation. "It's nice to see that the s... 
Printer Friendly Version
05/04/18Quest Diagnostics To Speak At The Deutsche Bank 43rd Annual Health Care Conference
SECAUCUS, N.J., May 4, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 43rd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 9, 2018 at 12:50 p.m. East... 
Printer Friendly Version
04/19/18Quest Diagnostics Reports First Quarter 2018 Financial Results
- Revenues of $1.88 billion, up 3.7% from 2017 - Reported diluted EPS of $1.27, up 9.5% from 2017 - Adjusted diluted EPS excluding amortization of $1.52, up 24.6% from 2017 - Outlook for full year 2018 remains unchanged SECAUCUS, N.J., April 19, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018. ... 
Printer Friendly Version
04/09/18New Survey: False Beliefs about Sexual Risk, Poor Physician-Patient Communication May Impede STD Screening in Young Women
One in four clinicians surveyed will disregard screening guidelines for chlamydia and/or gonorrhea if a patient is asymptomatic SECAUCUS, N.J., April 9, 2018 /PRNewswire/ -- Despite record high rates of new cases of sexually transmitted diseases (STDs), young women who are sexually active often don't talk to their clinicians about sex and STD risk, and many aren't being tested for infection or disease as guidelines recommend, according to new research from Quest Diagnostics (NYSE: DGX), the w... 
Printer Friendly Version
04/06/18Quest Diagnostics to Release First Quarter 2018 Financial Results on April 19
SECAUCUS, N.J., April 6, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2018 results on Thursday, April 19, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 773-756-0467... 
Printer Friendly Version
02/26/18Quest Diagnostics and Rutgers University Announce Sports Science Research Collaboration to Advance Athletic Performance
Collaboration will leverage insights from Quest’s Blueprint for Athletes biometric testing service data to examine physiological changes, performance variables in competitive athletes at the newly created Quest Diagnostics Sports Science Laboratory at the Rutgers–New Brunswick Center for Health & Human Performance Secaucus, NJ and New Brunswick, NJ, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, and Rutgers... 
Printer Friendly Version
02/22/18Quest Diagnostics To Speak At The Raymond James 39th Annual Institutional Investors Conference
SECAUCUS, N.J., Feb. 22, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Raymond James 39th Annual Institutional Investors Conference in Orlando. Mark Guinan, Executive Vice President and CFO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Tuesday, March 6, 2018 at ... 
Printer Friendly Version
02/01/18Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter
- Fourth quarter revenues of $1.94 billion, up 4.1% versus 2016 - Fourth quarter diluted EPS of $1.82 on a reported basis, up 67.0% from 2016 primarily due to a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.40 on an adjusted basis excluding amortization, up 6.9% from 2016. Excess tax benefit associated with stock based compensation (ETB) benefited diluted EPS by $0.02 in the quarter and increased $0.01 compared to 2016. - Full year revenues of $7.71 billion, ... 
Printer Friendly Version
02/01/18Quest Diagnostics Completes Acquisition of MedXM
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will stren... 
Printer Friendly Version
01/30/18ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
Tenth time ChartMaxx honored with top industry ranking* Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management solution ranked number one among Document Management and Imaging (DMI) software products in the 2018 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information techno... 
Printer Friendly Version
01/23/18Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care
Acquisition to strengthen Quest's mobile provider capabilities and population health management solutions for health plans SECAUCUS, N.J., Jan. 23, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. ... 
Printer Friendly Version
01/19/18Quest Diagnostics To Release Fourth Quarter And Full Year 2017 Financial Results On February 1
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2017 results on Thursday, February 1, 2018, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dia... 
Printer Friendly Version
01/19/18Quest Diagnostics Named One of 2018 "World's Most Admired Companies" by Fortune Magazine for Third Consecutive Year
SECAUCUS, N.J., Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2018 by Fortune for the third consecutive year.  The annual survey designated Quest Diagnostics as one of only five companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status.  The company advan... 
Printer Friendly Version
01/03/18Quest Diagnostics To Speak At The 36th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Jan. 3, 2018 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence.  The presentation is scheduled for Wednesday, January 10, 2018 at 12:... 
Printer Friendly Version